CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be made and what changes they would like to see.
Get insights on how to enhance specific areas of your practice, such as provider and scheduling performance, contact center efficiency and much more. Download the Guide Now.
Sionna Therapeutics found strong investor interest in its cystic fibrosis drugs, which could rival blockbuster Vertex Pharmaceuticals product Trikafta. The biotech has three internally developed programs that hit a target unaddressed by any currently available CF therapies.
At a moment when medication therapy for sickle cell disease (SCD) leaves too many behind and widespread access to curative gene therapies still lies in the distant future, automated red blood cell exchange is experiencing renewed interest. To improve patients' lives, a broad commitment is needed to expand access to transfusion therapies.
Kennedy emphasized that these inefficiencies aren't just administrative headaches, they're costing lives. Nowhere is this more evident than in organ-transplant logistics: the way organs get assigned – and move – from donors to patient recipients.
We kick off our first season of the MedCity Pivot Podcast by discussing ways healthcare organizations can protect themselves from being targets of a cybersecurity attack. A new IEEE Standard can help.
No comments